Chescapmanager LLC Cara Therapeutics, Inc. Transaction History

Chescapmanager LLC

  • $1.03 Billion
  • Q1 2024

A detailed history of Chescapmanager LLC transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Chescapmanager LLC holds 1,702,110 shares of CARA stock, worth $561,696. This represents 0.15% of its overall portfolio holdings.

Number of Shares
1,702,110
Previous 1,752,112 2.85%
Holding current value
$561,696
Previous $1.3 Million 19.44%
% of portfolio
0.15%
Previous 0.13%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$0.52 - $1.05 $26,001 - $52,502
-50,002 Reduced 2.85%
1,702,110 $1.55 Million
Q4 2023

Feb 14, 2024
BUY
$0.6 - $1.65 $57,921 - $159,284
96,536 Added 5.83%
1,752,112 $1.3 Million
Q2 2023

Aug 14, 2023
BUY
$2.83 - $4.94 $1.4 Million - $2.45 Million
495,184 Added 42.67%
1,655,576 $4.69 Million
Q2 2022

Aug 12, 2022
SELL
$7.45 - $13.84 $111,750 - $207,600
-15,000 Reduced 1.28%
1,160,392 $10.6 Million
Q1 2022

May 13, 2022
SELL
$9.94 - $12.65 $1.29 Million - $1.64 Million
-129,511 Reduced 9.92%
1,175,392 $14.3 Million
Q3 2021

Nov 15, 2021
BUY
$11.55 - $16.06 $3,465 - $4,818
300 Added 0.02%
1,304,903 $20.2 Million
Q2 2021

Aug 16, 2021
SELL
$12.38 - $29.19 $123,800 - $291,900
-10,000 Reduced 0.76%
1,304,603 $18.6 Million
Q4 2020

Feb 12, 2021
BUY
$12.72 - $16.16 $3,816 - $4,848
300 Added 0.02%
1,314,603 $19.9 Million
Q3 2020

Nov 16, 2020
SELL
$12.34 - $17.92 $2.1 Million - $3.05 Million
-170,000 Reduced 11.45%
1,314,303 $16.7 Million
Q2 2020

Aug 14, 2020
BUY
$12.39 - $17.33 $2.22 Million - $3.1 Million
178,894 Added 13.7%
1,484,303 $25.4 Million
Q1 2020

May 15, 2020
BUY
$9.12 - $17.78 $52,056 - $101,488
5,708 Added 0.44%
1,305,409 $17.2 Million
Q4 2019

Feb 12, 2020
BUY
$16.11 - $25.98 $926,325 - $1.49 Million
57,500 Added 4.63%
1,299,701 $20.9 Million
Q3 2019

Nov 14, 2019
BUY
$18.28 - $26.91 $2.56 Million - $3.77 Million
140,000 Added 12.7%
1,242,201 $22.7 Million
Q2 2019

Aug 14, 2019
SELL
$17.68 - $21.57 $1.78 Million - $2.18 Million
-100,854 Reduced 8.38%
1,102,201 $23.7 Million
Q1 2019

May 15, 2019
SELL
$14.41 - $19.64 $23,041 - $31,404
-1,599 Reduced 0.13%
1,203,055 $23.6 Million
Q3 2018

Nov 14, 2018
BUY
$17.57 - $23.95 $706,718 - $963,340
40,223 Added 3.45%
1,204,654 $28.9 Million
Q2 2018

Aug 10, 2018
BUY
$11.6 - $19.27 $1.29 Million - $2.15 Million
111,498 Added 10.59%
1,164,431 $22.3 Million
Q1 2018

May 14, 2018
BUY
$11.77 - $16.08 $235,400 - $321,599
20,000 Added 1.94%
1,052,933 $13 Million
Q4 2017

Feb 14, 2018
BUY
$11.86 - $14.08 $119,109 - $141,405
10,043 Added 0.98%
1,032,933 $12.6 Million
Q3 2017

Nov 13, 2017
BUY
$12.6 - $16.34 $56,700 - $73,530
4,500 Added 0.44%
1,022,890 $14 Million
Q2 2017

Aug 14, 2017
BUY
N/A
1,018,390
1,018,390 $15.7 Million

Others Institutions Holding CARA

# of Institutions
102
Shares Held
21.5M
Call Options Held
50K
Put Options Held
0
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $17.7M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Chescapmanager LLC Portfolio

Follow Chescapmanager LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chescapmanager LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chescapmanager LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email